A recent longitudinal study involving 699 adults from the InCHIANTI cohort has revealed that the rate of change in epigenetic clocks—derived from DNA methylation patterns—can be a significant predictor of mortality. Over a follow-up period of up to 24 years, researchers found that faster increases in various epigenetic clocks, including second- and third-generation models, were robustly associated with a higher risk of death, independent of baseline epigenetic age and other confounding factors.

These findings underscore the potential of dynamic epigenetic changes as sensitive indicators of health status, which could enhance the tracking of therapeutic interventions aimed at extending healthspan and longevity. The study highlights that while cross-sectional assessments of epigenetic age have been linked to health outcomes, understanding the temporal changes in these biomarkers may provide deeper insights into individual aging trajectories.

For professionals in the field, this research emphasizes the importance of integrating both baseline and longitudinal measurements of epigenetic clocks to improve mortality prediction models. As the field moves toward more personalized aging interventions, these insights could help refine strategies for monitoring and potentially mitigating the aging process.

Source: nature.com